Luke Miels

Chief Executive Officer at GSK PLC

Net worth: 11 M $ as of 2026-07-30

52 year

81 connections

Health Technology

Consumer Services

Commercial Services

Profile

Luke Victor Miels is currently Chief Executive Officer & Executive Director at GSK Plc since 2026, Director at ViiV Healthcare Co., and Member of the Singapore Economic Development Board.
Former roles include Executive VP-Global Portfolio & Product Strategy at AstraZeneca PLC and Regional VP-Asia Pacific & Pharmaceuticals Division at Roche Pharmaceuticals, Inc. Education includes an MBA from Macquarie University and undergraduate studies at Flinders University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
GSK PLC 0.01%	2026-07-09	413,119 ( 0.01% )	11 M $	2026-07-30

Latest news about Luke Miels

Jul. 28	GSK plc: Another beat; we appreciate the new CEO's aggressive intent
Jun. 11	Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal	RE
Apr. 29	GSK posts quarterly profit, sales beat in boost for new CEO Miels	RE
Apr. 29	GSK shares slide as investors question one-off result boost	RE
Apr. 12	GSK sees blockbuster potential in targeted cancer therapy after promising early data	RE

Luke Miels active positions

Companies	Position	Start
GSK PLC	Chief Executive Officer	2025-12-31
ViiV Healthcare Co. ViiV Healthcare Co. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, ViiV Healthcare is a pharmaceutical company that specializes in HIV medicines and research, with a focus on people living with HIV and AIDS. The company is based in Raleigh, NC. The company is committed to finding new ways to treat, prevent, and ultimately find a cure for HIV, while also focusing on bridging the gap between research and clinical practice through implementation science and patient-centered studies. ViiV Healthcare takes a holistic approach to developing new medicines and supporting sustainable community programs for the HIV community. The company's scientists have been at the forefront of developing innovative HIV medicines since the start of the HIV and AIDS epidemic. ViiV Exchange is a platform that provides healthcare professionals with access to product information, clinical data, publications, webcasts, and medical education related to HIV. The company is dedicated to treating, preventing, and eventually curing HIV.	Director/Board Member	-
Singapore Economic Development Board Singapore Economic Development Board General GovernmentGovernment Provides plans and excutives ecomomic strategies	Corporate Officer/Principal	-

All active positions of Luke Miels

Former positions of Luke Miels

Companies	Position	End
ASTRAZENECA PLC	Corporate Officer/Principal	2016-12-31
Roche Pharmaceuticals, Inc. Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services	Corporate Officer/Principal	-

See the detail of Luke Miels's experience

Training of Luke Miels

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Luke Miels's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Roche Pharmaceuticals, Inc. Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services	Commercial Services
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Singapore Economic Development Board Singapore Economic Development Board General GovernmentGovernment Provides plans and excutives ecomomic strategies	Government
Macquarie University Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Flinders University Flinders University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ViiV Healthcare Co. ViiV Healthcare Co. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, ViiV Healthcare is a pharmaceutical company that specializes in HIV medicines and research, with a focus on people living with HIV and AIDS. The company is based in Raleigh, NC. The company is committed to finding new ways to treat, prevent, and ultimately find a cure for HIV, while also focusing on bridging the gap between research and clinical practice through implementation science and patient-centered studies. ViiV Healthcare takes a holistic approach to developing new medicines and supporting sustainable community programs for the HIV community. The company's scientists have been at the forefront of developing innovative HIV medicines since the start of the HIV and AIDS epidemic. ViiV Exchange is a platform that provides healthcare professionals with access to product information, clinical data, publications, webcasts, and medical education related to HIV. The company is dedicated to treating, preventing, and eventually curing HIV.	Health Technology